nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—CYP2C9—brain cancer	0.519	1	CbGaD
Olanzapine—CYP2D6—Lomustine—brain cancer	0.0422	0.207	CbGbCtD
Olanzapine—CYP1A2—Carmustine—brain cancer	0.0417	0.205	CbGbCtD
Olanzapine—CYP2D6—Hydroxyurea—brain cancer	0.032	0.157	CbGbCtD
Olanzapine—CYP3A4—Temozolomide—brain cancer	0.0315	0.155	CbGbCtD
Olanzapine—CYP3A4—Lomustine—brain cancer	0.0268	0.132	CbGbCtD
Olanzapine—CYP1A2—Etoposide—brain cancer	0.0124	0.0607	CbGbCtD
Olanzapine—ABCB1—Etoposide—brain cancer	0.0108	0.0531	CbGbCtD
Olanzapine—CYP3A4—Etoposide—brain cancer	0.00648	0.0318	CbGbCtD
Olanzapine—DRD3—telencephalic ventricle—brain cancer	0.00332	0.0192	CbGeAlD
Olanzapine—HTR1D—trigeminal nerve—brain cancer	0.00322	0.0187	CbGeAlD
Olanzapine—HTR2A—choroid plexus—brain cancer	0.00317	0.0183	CbGeAlD
Olanzapine—HTR3A—cranial nerve—brain cancer	0.00283	0.0164	CbGeAlD
Olanzapine—HRH1—nose—brain cancer	0.00244	0.0141	CbGeAlD
Olanzapine—DRD1—telencephalic ventricle—brain cancer	0.00238	0.0138	CbGeAlD
Olanzapine—HTR1B—cranial nerve—brain cancer	0.00237	0.0137	CbGeAlD
Olanzapine—HTR7—vein—brain cancer	0.00232	0.0134	CbGeAlD
Olanzapine—HTR1D—cranial nerve—brain cancer	0.0023	0.0133	CbGeAlD
Olanzapine—HTR6—ganglion—brain cancer	0.00199	0.0115	CbGeAlD
Olanzapine—DRD5—ganglion—brain cancer	0.00194	0.0112	CbGeAlD
Olanzapine—HTR1B—telencephalic ventricle—brain cancer	0.00193	0.0112	CbGeAlD
Olanzapine—HTR1D—telencephalic ventricle—brain cancer	0.00187	0.0108	CbGeAlD
Olanzapine—HTR2C—telencephalic ventricle—brain cancer	0.00185	0.0107	CbGeAlD
Olanzapine—HTR7—cranial nerve—brain cancer	0.00183	0.0106	CbGeAlD
Olanzapine—HTR7—pons—brain cancer	0.00181	0.0105	CbGeAlD
Olanzapine—HTR2A—trigeminal nerve—brain cancer	0.0016	0.00927	CbGeAlD
Olanzapine—HTR2A—cerebellar cortex—brain cancer	0.00159	0.00923	CbGeAlD
Olanzapine—HTR1A—telencephalic ventricle—brain cancer	0.00156	0.00901	CbGeAlD
Olanzapine—HTR7—telencephalic ventricle—brain cancer	0.00149	0.00861	CbGeAlD
Olanzapine—DRD1—ganglion—brain cancer	0.00148	0.00858	CbGeAlD
Olanzapine—HTR2A—vein—brain cancer	0.00145	0.00838	CbGeAlD
Olanzapine—HTR3A—ganglion—brain cancer	0.00143	0.00828	CbGeAlD
Olanzapine—HTR5A—head—brain cancer	0.00143	0.00827	CbGeAlD
Olanzapine—DRD2—telencephalic ventricle—brain cancer	0.00141	0.00814	CbGeAlD
Olanzapine—HTR5A—central nervous system—brain cancer	0.0013	0.00755	CbGeAlD
Olanzapine—HTR1B—ganglion—brain cancer	0.0012	0.00695	CbGeAlD
Olanzapine—HTR1D—ganglion—brain cancer	0.00116	0.00673	CbGeAlD
Olanzapine—HTR2C—ganglion—brain cancer	0.00115	0.00666	CbGeAlD
Olanzapine—HTR2A—cranial nerve—brain cancer	0.00114	0.0066	CbGeAlD
Olanzapine—HTR2A—pons—brain cancer	0.00113	0.00653	CbGeAlD
Olanzapine—HTR1E—brainstem—brain cancer	0.0011	0.00639	CbGeAlD
Olanzapine—HTR5A—brain—brain cancer	0.00104	0.00599	CbGeAlD
Olanzapine—HTR1E—telencephalon—brain cancer	0.000979	0.00567	CbGeAlD
Olanzapine—HTR1A—ganglion—brain cancer	0.000969	0.00561	CbGeAlD
Olanzapine—HTR1B—blood vessel—brain cancer	0.000955	0.00553	CbGeAlD
Olanzapine—HTR2A—telencephalic ventricle—brain cancer	0.000928	0.00537	CbGeAlD
Olanzapine—HTR7—ganglion—brain cancer	0.000926	0.00536	CbGeAlD
Olanzapine—HTR1D—blood vessel—brain cancer	0.000924	0.00535	CbGeAlD
Olanzapine—DRD2—ganglion—brain cancer	0.000875	0.00507	CbGeAlD
Olanzapine—HTR2A—pineal body—brain cancer	0.000805	0.00466	CbGeAlD
Olanzapine—HTR7—endothelium—brain cancer	0.000798	0.00462	CbGeAlD
Olanzapine—HTR6—telencephalon—brain cancer	0.000768	0.00445	CbGeAlD
Olanzapine—DRD5—telencephalon—brain cancer	0.000748	0.00433	CbGeAlD
Olanzapine—HTR7—blood vessel—brain cancer	0.000736	0.00426	CbGeAlD
Olanzapine—HTR1A—hindbrain—brain cancer	0.000735	0.00425	CbGeAlD
Olanzapine—HTR7—hindbrain—brain cancer	0.000702	0.00407	CbGeAlD
Olanzapine—ADRA1A—hindbrain—brain cancer	0.000677	0.00392	CbGeAlD
Olanzapine—DRD2—hindbrain—brain cancer	0.000664	0.00384	CbGeAlD
Olanzapine—DRD1—brainstem—brain cancer	0.000644	0.00373	CbGeAlD
Olanzapine—FMO3—pituitary gland—brain cancer	0.000643	0.00372	CbGeAlD
Olanzapine—HTR3A—brainstem—brain cancer	0.000622	0.0036	CbGeAlD
Olanzapine—HTR1E—head—brain cancer	0.00061	0.00353	CbGeAlD
Olanzapine—H1F0—telencephalon—brain cancer	0.000579	0.00335	CbGeAlD
Olanzapine—HTR2A—ganglion—brain cancer	0.000577	0.00334	CbGeAlD
Olanzapine—DRD1—telencephalon—brain cancer	0.000572	0.00331	CbGeAlD
Olanzapine—HTR1E—central nervous system—brain cancer	0.000557	0.00322	CbGeAlD
Olanzapine—HTR3A—telencephalon—brain cancer	0.000552	0.0032	CbGeAlD
Olanzapine—CHRM4—head—brain cancer	0.000535	0.0031	CbGeAlD
Olanzapine—HTR1B—brainstem—brain cancer	0.000522	0.00302	CbGeAlD
Olanzapine—DRD4—brain—brain cancer	0.000512	0.00297	CbGeAlD
Olanzapine—HTR1D—brainstem—brain cancer	0.000505	0.00292	CbGeAlD
Olanzapine—HTR2C—brainstem—brain cancer	0.0005	0.0029	CbGeAlD
Olanzapine—HTR2A—endothelium—brain cancer	0.000498	0.00288	CbGeAlD
Olanzapine—FMO3—endocrine gland—brain cancer	0.000498	0.00288	CbGeAlD
Olanzapine—DRD3—head—brain cancer	0.000497	0.00288	CbGeAlD
Olanzapine—FMO3—head—brain cancer	0.000492	0.00285	CbGeAlD
Olanzapine—CHRM4—central nervous system—brain cancer	0.000488	0.00283	CbGeAlD
Olanzapine—H1F0—gonad—brain cancer	0.000483	0.0028	CbGeAlD
Olanzapine—HTR6—head—brain cancer	0.000478	0.00277	CbGeAlD
Olanzapine—DRD5—endocrine gland—brain cancer	0.000472	0.00273	CbGeAlD
Olanzapine—H1F0—pituitary gland—brain cancer	0.000471	0.00273	CbGeAlD
Olanzapine—DRD5—head—brain cancer	0.000466	0.0027	CbGeAlD
Olanzapine—HTR1B—telencephalon—brain cancer	0.000463	0.00268	CbGeAlD
Olanzapine—CHRM2—telencephalon—brain cancer	0.000461	0.00267	CbGeAlD
Olanzapine—HTR2A—blood vessel—brain cancer	0.000459	0.00266	CbGeAlD
Olanzapine—H1F0—medulla oblongata—brain cancer	0.000455	0.00263	CbGeAlD
Olanzapine—DRD3—central nervous system—brain cancer	0.000454	0.00263	CbGeAlD
Olanzapine—FMO3—central nervous system—brain cancer	0.000449	0.0026	CbGeAlD
Olanzapine—HTR1D—telencephalon—brain cancer	0.000448	0.0026	CbGeAlD
Olanzapine—HTR2C—telencephalon—brain cancer	0.000444	0.00257	CbGeAlD
Olanzapine—HRH2—endocrine gland—brain cancer	0.000443	0.00257	CbGeAlD
Olanzapine—HTR1E—brain—brain cancer	0.000442	0.00256	CbGeAlD
Olanzapine—HTR2A—hindbrain—brain cancer	0.000438	0.00254	CbGeAlD
Olanzapine—HRH2—head—brain cancer	0.000437	0.00253	CbGeAlD
Olanzapine—HTR6—central nervous system—brain cancer	0.000437	0.00253	CbGeAlD
Olanzapine—DRD5—central nervous system—brain cancer	0.000425	0.00246	CbGeAlD
Olanzapine—HTR1A—brainstem—brain cancer	0.000421	0.00244	CbGeAlD
Olanzapine—CHRM1—telencephalon—brain cancer	0.000419	0.00243	CbGeAlD
Olanzapine—CHRM5—head—brain cancer	0.000418	0.00242	CbGeAlD
Olanzapine—HTR2B—telencephalon—brain cancer	0.000417	0.00241	CbGeAlD
Olanzapine—H1F0—midbrain—brain cancer	0.000416	0.00241	CbGeAlD
Olanzapine—DRD1—midbrain—brain cancer	0.00041	0.00238	CbGeAlD
Olanzapine—H1F0—spinal cord—brain cancer	0.000406	0.00235	CbGeAlD
Olanzapine—HTR7—brainstem—brain cancer	0.000402	0.00233	CbGeAlD
Olanzapine—HRH2—central nervous system—brain cancer	0.000399	0.00231	CbGeAlD
Olanzapine—CYP2D6—hindbrain—brain cancer	0.000399	0.00231	CbGeAlD
Olanzapine—ADRA1A—brainstem—brain cancer	0.000388	0.00225	CbGeAlD
Olanzapine—CHRM4—brain—brain cancer	0.000387	0.00224	CbGeAlD
Olanzapine—ADRA1B—head—brain cancer	0.000382	0.00221	CbGeAlD
Olanzapine—CHRM5—central nervous system—brain cancer	0.000381	0.00221	CbGeAlD
Olanzapine—DRD2—brainstem—brain cancer	0.000381	0.0022	CbGeAlD
Olanzapine—CHRM3—telencephalon—brain cancer	0.000375	0.00217	CbGeAlD
Olanzapine—HTR1A—telencephalon—brain cancer	0.000374	0.00216	CbGeAlD
Olanzapine—H1F0—endocrine gland—brain cancer	0.000365	0.00211	CbGeAlD
Olanzapine—H1F0—head—brain cancer	0.00036	0.00209	CbGeAlD
Olanzapine—DRD3—brain—brain cancer	0.00036	0.00209	CbGeAlD
Olanzapine—HTR7—telencephalon—brain cancer	0.000357	0.00207	CbGeAlD
Olanzapine—FMO3—brain—brain cancer	0.000356	0.00206	CbGeAlD
Olanzapine—DRD1—head—brain cancer	0.000356	0.00206	CbGeAlD
Olanzapine—HTR2C—medulla oblongata—brain cancer	0.000349	0.00202	CbGeAlD
Olanzapine—ADRA1B—central nervous system—brain cancer	0.000349	0.00202	CbGeAlD
Olanzapine—HTR6—brain—brain cancer	0.000347	0.00201	CbGeAlD
Olanzapine—ORM1—spinal cord—brain cancer	0.000346	0.002	CbGeAlD
Olanzapine—ADRA1A—telencephalon—brain cancer	0.000345	0.00199	CbGeAlD
Olanzapine—HTR3A—head—brain cancer	0.000344	0.00199	CbGeAlD
Olanzapine—DRD2—telencephalon—brain cancer	0.000338	0.00195	CbGeAlD
Olanzapine—DRD5—brain—brain cancer	0.000338	0.00195	CbGeAlD
Olanzapine—HTR1B—midbrain—brain cancer	0.000333	0.00193	CbGeAlD
Olanzapine—H1F0—central nervous system—brain cancer	0.000329	0.0019	CbGeAlD
Olanzapine—ADRA2C—telencephalon—brain cancer	0.000328	0.0019	CbGeAlD
Olanzapine—DRD1—central nervous system—brain cancer	0.000325	0.00188	CbGeAlD
Olanzapine—HTR1B—spinal cord—brain cancer	0.000325	0.00188	CbGeAlD
Olanzapine—HTR1D—midbrain—brain cancer	0.000322	0.00186	CbGeAlD
Olanzapine—H1F0—cerebellum—brain cancer	0.000322	0.00186	CbGeAlD
Olanzapine—HTR2C—midbrain—brain cancer	0.000319	0.00185	CbGeAlD
Olanzapine—HRH2—brain—brain cancer	0.000317	0.00184	CbGeAlD
Olanzapine—HTR3A—central nervous system—brain cancer	0.000314	0.00182	CbGeAlD
Olanzapine—ORM1—endocrine gland—brain cancer	0.000312	0.0018	CbGeAlD
Olanzapine—HTR2C—spinal cord—brain cancer	0.000311	0.0018	CbGeAlD
Olanzapine—CHRM5—brain—brain cancer	0.000303	0.00175	CbGeAlD
Olanzapine—ABCB1—blood vessel—brain cancer	0.000301	0.00174	CbGeAlD
Olanzapine—HTR7—gonad—brain cancer	0.000298	0.00173	CbGeAlD
Olanzapine—HTR1B—endocrine gland—brain cancer	0.000292	0.00169	CbGeAlD
Olanzapine—CHRM2—endocrine gland—brain cancer	0.000291	0.00168	CbGeAlD
Olanzapine—HTR1B—head—brain cancer	0.000288	0.00167	CbGeAlD
Olanzapine—CHRM2—head—brain cancer	0.000287	0.00166	CbGeAlD
Olanzapine—ORM1—central nervous system—brain cancer	0.000281	0.00163	CbGeAlD
Olanzapine—HTR7—medulla oblongata—brain cancer	0.000281	0.00162	CbGeAlD
Olanzapine—HTR1D—head—brain cancer	0.000279	0.00162	CbGeAlD
Olanzapine—ADRA1B—brain—brain cancer	0.000277	0.0016	CbGeAlD
Olanzapine—HTR2C—head—brain cancer	0.000277	0.0016	CbGeAlD
Olanzapine—DRD2—pituitary gland—brain cancer	0.000275	0.00159	CbGeAlD
Olanzapine—HTR1A—midbrain—brain cancer	0.000268	0.00155	CbGeAlD
Olanzapine—ADRA2C—pituitary gland—brain cancer	0.000267	0.00155	CbGeAlD
Olanzapine—HRH1—telencephalon—brain cancer	0.000267	0.00154	CbGeAlD
Olanzapine—CHRM1—endocrine gland—brain cancer	0.000264	0.00153	CbGeAlD
Olanzapine—HTR1B—central nervous system—brain cancer	0.000263	0.00152	CbGeAlD
Olanzapine—ADRA2A—telencephalon—brain cancer	0.000262	0.00152	CbGeAlD
Olanzapine—HTR1A—spinal cord—brain cancer	0.000262	0.00152	CbGeAlD
Olanzapine—CHRM2—central nervous system—brain cancer	0.000262	0.00152	CbGeAlD
Olanzapine—H1F0—brain—brain cancer	0.000261	0.00151	CbGeAlD
Olanzapine—CHRM1—head—brain cancer	0.000261	0.00151	CbGeAlD
Olanzapine—HTR2B—head—brain cancer	0.00026	0.0015	CbGeAlD
Olanzapine—ADRA2C—medulla oblongata—brain cancer	0.000258	0.00149	CbGeAlD
Olanzapine—DRD1—brain—brain cancer	0.000258	0.00149	CbGeAlD
Olanzapine—HTR7—midbrain—brain cancer	0.000257	0.00148	CbGeAlD
Olanzapine—HTR1D—central nervous system—brain cancer	0.000255	0.00148	CbGeAlD
Olanzapine—HTR2C—central nervous system—brain cancer	0.000252	0.00146	CbGeAlD
Olanzapine—HTR2A—brainstem—brain cancer	0.000251	0.00145	CbGeAlD
Olanzapine—HTR7—spinal cord—brain cancer	0.00025	0.00145	CbGeAlD
Olanzapine—HTR3A—brain—brain cancer	0.000249	0.00144	CbGeAlD
Olanzapine—DRD2—midbrain—brain cancer	0.000243	0.0014	CbGeAlD
Olanzapine—CHRM1—central nervous system—brain cancer	0.000238	0.00138	CbGeAlD
Olanzapine—HTR2B—central nervous system—brain cancer	0.000237	0.00137	CbGeAlD
Olanzapine—CHRM3—endocrine gland—brain cancer	0.000237	0.00137	CbGeAlD
Olanzapine—ADRA2C—midbrain—brain cancer	0.000236	0.00136	CbGeAlD
Olanzapine—HTR1A—endocrine gland—brain cancer	0.000236	0.00136	CbGeAlD
Olanzapine—CHRM3—head—brain cancer	0.000234	0.00135	CbGeAlD
Olanzapine—HTR1A—head—brain cancer	0.000233	0.00135	CbGeAlD
Olanzapine—ADRA2C—spinal cord—brain cancer	0.00023	0.00133	CbGeAlD
Olanzapine—CYP2D6—brainstem—brain cancer	0.000229	0.00132	CbGeAlD
Olanzapine—HTR7—endocrine gland—brain cancer	0.000225	0.0013	CbGeAlD
Olanzapine—HTR2A—telencephalon—brain cancer	0.000223	0.00129	CbGeAlD
Olanzapine—HTR7—head—brain cancer	0.000222	0.00129	CbGeAlD
Olanzapine—CYP2C19—endocrine gland—brain cancer	0.00022	0.00127	CbGeAlD
Olanzapine—ADRA2A—gonad—brain cancer	0.000219	0.00127	CbGeAlD
Olanzapine—ADRA1A—endocrine gland—brain cancer	0.000217	0.00126	CbGeAlD
Olanzapine—ADRA1A—head—brain cancer	0.000215	0.00124	CbGeAlD
Olanzapine—ADRA2A—pituitary gland—brain cancer	0.000213	0.00123	CbGeAlD
Olanzapine—CHRM3—central nervous system—brain cancer	0.000213	0.00123	CbGeAlD
Olanzapine—DRD2—endocrine gland—brain cancer	0.000213	0.00123	CbGeAlD
Olanzapine—HTR1A—central nervous system—brain cancer	0.000212	0.00123	CbGeAlD
Olanzapine—DRD2—head—brain cancer	0.00021	0.00122	CbGeAlD
Olanzapine—HTR1B—brain—brain cancer	0.000209	0.00121	CbGeAlD
Olanzapine—CHRM2—brain—brain cancer	0.000208	0.0012	CbGeAlD
Olanzapine—HTR1A—cerebellum—brain cancer	0.000208	0.0012	CbGeAlD
Olanzapine—ADRA2A—medulla oblongata—brain cancer	0.000206	0.00119	CbGeAlD
Olanzapine—ADRA2C—head—brain cancer	0.000204	0.00118	CbGeAlD
Olanzapine—HTR7—central nervous system—brain cancer	0.000203	0.00118	CbGeAlD
Olanzapine—CYP2D6—telencephalon—brain cancer	0.000203	0.00117	CbGeAlD
Olanzapine—HTR1D—brain—brain cancer	0.000202	0.00117	CbGeAlD
Olanzapine—HTR2C—brain—brain cancer	0.0002	0.00116	CbGeAlD
Olanzapine—HTR7—cerebellum—brain cancer	0.000198	0.00115	CbGeAlD
Olanzapine—ADRA1A—central nervous system—brain cancer	0.000196	0.00113	CbGeAlD
Olanzapine—ALB—brain—brain cancer	0.000195	0.00113	CbGeAlD
Olanzapine—DRD2—central nervous system—brain cancer	0.000192	0.00111	CbGeAlD
Olanzapine—ADRA1A—cerebellum—brain cancer	0.000191	0.00111	CbGeAlD
Olanzapine—CHRM1—brain—brain cancer	0.000189	0.0011	CbGeAlD
Olanzapine—HTR2B—brain—brain cancer	0.000188	0.00109	CbGeAlD
Olanzapine—ADRA2A—midbrain—brain cancer	0.000188	0.00109	CbGeAlD
Olanzapine—DRD2—cerebellum—brain cancer	0.000188	0.00109	CbGeAlD
Olanzapine—ADRA2C—central nervous system—brain cancer	0.000187	0.00108	CbGeAlD
Olanzapine—HTR2A—gonad—brain cancer	0.000186	0.00108	CbGeAlD
Olanzapine—ADRA2A—spinal cord—brain cancer	0.000184	0.00106	CbGeAlD
Olanzapine—ADRA2C—cerebellum—brain cancer	0.000182	0.00106	CbGeAlD
Olanzapine—HTR2A—pituitary gland—brain cancer	0.000181	0.00105	CbGeAlD
Olanzapine—CYP1A2—endocrine gland—brain cancer	0.00018	0.00104	CbGeAlD
Olanzapine—HTR2A—medulla oblongata—brain cancer	0.000175	0.00101	CbGeAlD
Olanzapine—CYP2C9—endocrine gland—brain cancer	0.000171	0.000987	CbGeAlD
Olanzapine—CHRM3—brain—brain cancer	0.000169	0.00098	CbGeAlD
Olanzapine—HTR1A—brain—brain cancer	0.000169	0.000976	CbGeAlD
Olanzapine—HRH1—endocrine gland—brain cancer	0.000168	0.000974	CbGeAlD
Olanzapine—HRH1—head—brain cancer	0.000166	0.000961	CbGeAlD
Olanzapine—ADRA2A—endocrine gland—brain cancer	0.000165	0.000957	CbGeAlD
Olanzapine—ADRA2A—head—brain cancer	0.000163	0.000944	CbGeAlD
Olanzapine—HTR7—brain—brain cancer	0.000161	0.000933	CbGeAlD
Olanzapine—HTR2A—midbrain—brain cancer	0.00016	0.000926	CbGeAlD
Olanzapine—HTR2A—spinal cord—brain cancer	0.000156	0.000903	CbGeAlD
Olanzapine—ADRA1A—brain—brain cancer	0.000155	0.0009	CbGeAlD
Olanzapine—DRD2—brain—brain cancer	0.000152	0.000882	CbGeAlD
Olanzapine—HRH1—central nervous system—brain cancer	0.000152	0.000878	CbGeAlD
Olanzapine—ADRA2A—central nervous system—brain cancer	0.000149	0.000862	CbGeAlD
Olanzapine—ADRA2C—brain—brain cancer	0.000148	0.000858	CbGeAlD
Olanzapine—ABCB1—telencephalon—brain cancer	0.000146	0.000845	CbGeAlD
Olanzapine—ADRA2A—cerebellum—brain cancer	0.000146	0.000842	CbGeAlD
Olanzapine—HTR2A—endocrine gland—brain cancer	0.00014	0.000813	CbGeAlD
Olanzapine—HTR2A—head—brain cancer	0.000139	0.000803	CbGeAlD
Olanzapine—CYP3A4—endocrine gland—brain cancer	0.00013	0.000753	CbGeAlD
Olanzapine—CYP2D6—endocrine gland—brain cancer	0.000128	0.000741	CbGeAlD
Olanzapine—HTR2A—central nervous system—brain cancer	0.000127	0.000733	CbGeAlD
Olanzapine—CYP2D6—head—brain cancer	0.000126	0.000731	CbGeAlD
Olanzapine—HTR2A—cerebellum—brain cancer	0.000124	0.000716	CbGeAlD
Olanzapine—ABCB1—gonad—brain cancer	0.000122	0.000705	CbGeAlD
Olanzapine—HRH1—brain—brain cancer	0.00012	0.000697	CbGeAlD
Olanzapine—ABCB1—pituitary gland—brain cancer	0.000119	0.000688	CbGeAlD
Olanzapine—ADRA2A—brain—brain cancer	0.000118	0.000684	CbGeAlD
Olanzapine—CYP3A4—central nervous system—brain cancer	0.000117	0.000678	CbGeAlD
Olanzapine—CYP2D6—central nervous system—brain cancer	0.000115	0.000668	CbGeAlD
Olanzapine—ABCB1—medulla oblongata—brain cancer	0.000115	0.000664	CbGeAlD
Olanzapine—CYP2D6—cerebellum—brain cancer	0.000113	0.000653	CbGeAlD
Olanzapine—ABCB1—midbrain—brain cancer	0.000105	0.000607	CbGeAlD
Olanzapine—ABCB1—spinal cord—brain cancer	0.000102	0.000592	CbGeAlD
Olanzapine—HTR2A—brain—brain cancer	0.000101	0.000582	CbGeAlD
Olanzapine—ABCB1—endocrine gland—brain cancer	9.21e-05	0.000533	CbGeAlD
Olanzapine—CYP2D6—brain—brain cancer	9.16e-05	0.00053	CbGeAlD
Olanzapine—ABCB1—head—brain cancer	9.09e-05	0.000526	CbGeAlD
Olanzapine—ABCB1—central nervous system—brain cancer	8.3e-05	0.00048	CbGeAlD
Olanzapine—ABCB1—cerebellum—brain cancer	8.11e-05	0.000469	CbGeAlD
Olanzapine—ABCB1—brain—brain cancer	6.59e-05	0.000381	CbGeAlD
Olanzapine—HTR1B—Signaling Pathways—IL2—brain cancer	6.73e-06	6.44e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—CCND1—brain cancer	6.7e-06	6.41e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—CTNNB1—brain cancer	6.68e-06	6.4e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—CTNNB1—brain cancer	6.68e-06	6.39e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling by GPCR—EGFR—brain cancer	6.63e-06	6.35e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—CTNNB1—brain cancer	6.63e-06	6.35e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IL2—brain cancer	6.62e-06	6.33e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—RELA—brain cancer	6.62e-06	6.33e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling by GPCR—EGFR—brain cancer	6.6e-06	6.32e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—ERBB2—brain cancer	6.58e-06	6.29e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—CCND1—brain cancer	6.56e-06	6.28e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IL2—brain cancer	6.53e-06	6.25e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—RELA—brain cancer	6.53e-06	6.25e-05	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—TP53—brain cancer	6.51e-06	6.23e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—CTNNB1—brain cancer	6.49e-06	6.21e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—ERBB2—brain cancer	6.49e-06	6.21e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IRS2—brain cancer	6.48e-06	6.2e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—CCND1—brain cancer	6.45e-06	6.18e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling by GPCR—EGFR—brain cancer	6.42e-06	6.14e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—APC—brain cancer	6.39e-06	6.12e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—PIK3CG—brain cancer	6.39e-06	6.12e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—CTNNB1—brain cancer	6.39e-06	6.12e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—CCND1—brain cancer	6.37e-06	6.09e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—ENO2—brain cancer	6.36e-06	6.08e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IL2—brain cancer	6.32e-06	6.05e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	6.32e-06	6.05e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—CTNNB1—brain cancer	6.3e-06	6.03e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	6.29e-06	6.02e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—APC—brain cancer	6.29e-06	6.02e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—APC—brain cancer	6.28e-06	6.01e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PIK3CG—brain cancer	6.28e-06	6.01e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—APC—brain cancer	6.26e-06	5.99e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	6.26e-06	5.99e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IL2—brain cancer	6.25e-06	5.98e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—APC—brain cancer	6.24e-06	5.97e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PIK3CG—brain cancer	6.24e-06	5.97e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—APC—brain cancer	6.18e-06	5.91e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	6.18e-06	5.91e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—CCND1—brain cancer	6.16e-06	5.9e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—APC—brain cancer	6.16e-06	5.89e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	6.16e-06	5.89e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—CTNNB1—brain cancer	6.1e-06	5.84e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—CCND1—brain cancer	6.1e-06	5.83e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—CTNNB1—brain cancer	6.04e-06	5.78e-05	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—TP53—brain cancer	6.02e-06	5.76e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IL2—brain cancer	5.96e-06	5.7e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—RELA—brain cancer	5.89e-06	5.64e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—VEGFA—brain cancer	5.88e-06	5.63e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IL2—brain cancer	5.88e-06	5.63e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—VEGFA—brain cancer	5.88e-06	5.62e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—ERBB2—brain cancer	5.86e-06	5.61e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—VEGFA—brain cancer	5.84e-06	5.59e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—STAT3—brain cancer	5.83e-06	5.57e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling by GPCR—EGFR—brain cancer	5.82e-06	5.57e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—STAT3—brain cancer	5.82e-06	5.57e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—CCND1—brain cancer	5.81e-06	5.56e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—TP53—brain cancer	5.8e-06	5.55e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—STAT3—brain cancer	5.78e-06	5.53e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—TP53—brain cancer	5.76e-06	5.51e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—CTNNB1—brain cancer	5.75e-06	5.51e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—CCND1—brain cancer	5.73e-06	5.49e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling by GPCR—EGFR—brain cancer	5.73e-06	5.48e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—APC—brain cancer	5.72e-06	5.48e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	5.72e-06	5.48e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling by GPCR—EGFR—brain cancer	5.72e-06	5.47e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—VEGFA—brain cancer	5.72e-06	5.47e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling by GPCR—EGFR—brain cancer	5.7e-06	5.46e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—RELA—brain cancer	5.69e-06	5.45e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling by GPCR—EGFR—brain cancer	5.68e-06	5.44e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—CTNNB1—brain cancer	5.68e-06	5.43e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—RELA—brain cancer	5.66e-06	5.42e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—STAT3—brain cancer	5.66e-06	5.42e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—ERBB2—brain cancer	5.65e-06	5.41e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling by GPCR—EGFR—brain cancer	5.63e-06	5.39e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—VEGFA—brain cancer	5.63e-06	5.38e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—ERBB2—brain cancer	5.63e-06	5.38e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	5.61e-06	5.37e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—STAT3—brain cancer	5.57e-06	5.33e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—VEGFA—brain cancer	5.55e-06	5.31e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—RELA—brain cancer	5.51e-06	5.27e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—STAT3—brain cancer	5.5e-06	5.26e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—ERBB2—brain cancer	5.47e-06	5.24e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—RELA—brain cancer	5.42e-06	5.19e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—MYC—brain cancer	5.41e-06	5.18e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—MYC—brain cancer	5.41e-06	5.17e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PIK3CG—brain cancer	5.4e-06	5.17e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	5.38e-06	5.15e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—MYC—brain cancer	5.37e-06	5.14e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—VEGFA—brain cancer	5.37e-06	5.14e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—STAT3—brain cancer	5.32e-06	5.09e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—VEGFA—brain cancer	5.31e-06	5.09e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IL2—brain cancer	5.31e-06	5.08e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—EGFR—brain cancer	5.29e-06	5.07e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—EGFR—brain cancer	5.29e-06	5.06e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—STAT3—brain cancer	5.26e-06	5.04e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—MYC—brain cancer	5.26e-06	5.03e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—EGFR—brain cancer	5.25e-06	5.03e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling by GPCR—EGFR—brain cancer	5.21e-06	4.99e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—MYC—brain cancer	5.18e-06	4.95e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CCND1—brain cancer	5.17e-06	4.95e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—EGFR—brain cancer	5.14e-06	4.92e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	5.12e-06	4.9e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IL2—brain cancer	5.12e-06	4.9e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—MYC—brain cancer	5.11e-06	4.89e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IL2—brain cancer	5.1e-06	4.88e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—VEGFA—brain cancer	5.06e-06	4.85e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—EGFR—brain cancer	5.06e-06	4.84e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—STAT3—brain cancer	5.01e-06	4.8e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—VEGFA—brain cancer	5e-06	4.78e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—RELA—brain cancer	5e-06	4.78e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CCND1—brain cancer	5e-06	4.78e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—EGFR—brain cancer	4.99e-06	4.78e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CCND1—brain cancer	4.97e-06	4.76e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—ERBB2—brain cancer	4.96e-06	4.75e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IL2—brain cancer	4.96e-06	4.75e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—STAT3—brain cancer	4.95e-06	4.74e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CTNNB1—brain cancer	4.95e-06	4.73e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—MYC—brain cancer	4.94e-06	4.73e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	4.92e-06	4.71e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—RELA—brain cancer	4.92e-06	4.7e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—RELA—brain cancer	4.9e-06	4.69e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MYC—brain cancer	4.89e-06	4.68e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—RELA—brain cancer	4.89e-06	4.68e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—ERBB2—brain cancer	4.88e-06	4.67e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IL2—brain cancer	4.88e-06	4.67e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—ERBB2—brain cancer	4.87e-06	4.66e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—RELA—brain cancer	4.87e-06	4.66e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—ERBB2—brain cancer	4.86e-06	4.65e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PIK3CG—brain cancer	4.85e-06	4.64e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—ERBB2—brain cancer	4.84e-06	4.63e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CCND1—brain cancer	4.83e-06	4.63e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—EGFR—brain cancer	4.83e-06	4.63e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—RELA—brain cancer	4.83e-06	4.62e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—RELA—brain cancer	4.81e-06	4.61e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—ERBB2—brain cancer	4.8e-06	4.59e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	4.79e-06	4.58e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	4.78e-06	4.58e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—EGFR—brain cancer	4.78e-06	4.58e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CCND1—brain cancer	4.76e-06	4.55e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PIK3CG—brain cancer	4.73e-06	4.53e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	4.71e-06	4.51e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MYC—brain cancer	4.66e-06	4.46e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MYC—brain cancer	4.6e-06	4.4e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—EGFR—brain cancer	4.56e-06	4.36e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—VEGFA—brain cancer	4.51e-06	4.32e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IL2—brain cancer	4.5e-06	4.31e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—EGFR—brain cancer	4.5e-06	4.3e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—RELA—brain cancer	4.47e-06	4.28e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—STAT3—brain cancer	4.47e-06	4.27e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PIK3CG—brain cancer	4.46e-06	4.27e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—TP53—brain cancer	4.45e-06	4.25e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—ERBB2—brain cancer	4.44e-06	4.25e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—TP53—brain cancer	4.44e-06	4.25e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IL2—brain cancer	4.43e-06	4.24e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.42e-06	4.23e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IL2—brain cancer	4.42e-06	4.23e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—TP53—brain cancer	4.41e-06	4.22e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IL2—brain cancer	4.4e-06	4.21e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IL2—brain cancer	4.39e-06	4.2e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CCND1—brain cancer	4.39e-06	4.2e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—VEGFA—brain cancer	4.35e-06	4.17e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IL2—brain cancer	4.35e-06	4.16e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CTNNB1—brain cancer	4.34e-06	4.16e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IL2—brain cancer	4.33e-06	4.15e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—VEGFA—brain cancer	4.33e-06	4.15e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—TP53—brain cancer	4.32e-06	4.13e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CCND1—brain cancer	4.32e-06	4.13e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—STAT3—brain cancer	4.31e-06	4.13e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CCND1—brain cancer	4.31e-06	4.12e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CCND1—brain cancer	4.29e-06	4.11e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—STAT3—brain cancer	4.29e-06	4.11e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CCND1—brain cancer	4.28e-06	4.09e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	4.27e-06	4.09e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CTNNB1—brain cancer	4.26e-06	4.08e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	4.25e-06	4.07e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—TP53—brain cancer	4.25e-06	4.07e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CCND1—brain cancer	4.24e-06	4.06e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CTNNB1—brain cancer	4.24e-06	4.06e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CCND1—brain cancer	4.23e-06	4.04e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—VEGFA—brain cancer	4.21e-06	4.03e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	4.2e-06	4.02e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TP53—brain cancer	4.19e-06	4.01e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	4.18e-06	4e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—STAT3—brain cancer	4.17e-06	3.99e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MYC—brain cancer	4.15e-06	3.97e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	4.15e-06	3.97e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—STAT3—brain cancer	4.11e-06	3.93e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—EGFR—brain cancer	4.06e-06	3.89e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TP53—brain cancer	4.06e-06	3.88e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IL2—brain cancer	4.03e-06	3.85e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TP53—brain cancer	4.02e-06	3.84e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MYC—brain cancer	4.01e-06	3.83e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MYC—brain cancer	3.99e-06	3.81e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CCND1—brain cancer	3.93e-06	3.76e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—EGFR—brain cancer	3.92e-06	3.75e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—EGFR—brain cancer	3.9e-06	3.73e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	3.89e-06	3.72e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MYC—brain cancer	3.88e-06	3.71e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TP53—brain cancer	3.83e-06	3.66e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VEGFA—brain cancer	3.82e-06	3.66e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MYC—brain cancer	3.82e-06	3.65e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—EGFR—brain cancer	3.79e-06	3.63e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—STAT3—brain cancer	3.79e-06	3.62e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PIK3CG—brain cancer	3.78e-06	3.62e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TP53—brain cancer	3.78e-06	3.61e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VEGFA—brain cancer	3.76e-06	3.6e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VEGFA—brain cancer	3.75e-06	3.59e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VEGFA—brain cancer	3.74e-06	3.58e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—EGFR—brain cancer	3.73e-06	3.57e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VEGFA—brain cancer	3.73e-06	3.57e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—STAT3—brain cancer	3.73e-06	3.57e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—STAT3—brain cancer	3.72e-06	3.56e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—STAT3—brain cancer	3.71e-06	3.55e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VEGFA—brain cancer	3.69e-06	3.54e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—STAT3—brain cancer	3.69e-06	3.53e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	3.68e-06	3.53e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—STAT3—brain cancer	3.66e-06	3.5e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—STAT3—brain cancer	3.65e-06	3.49e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MYC—brain cancer	3.52e-06	3.37e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MYC—brain cancer	3.46e-06	3.31e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MYC—brain cancer	3.45e-06	3.31e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MYC—brain cancer	3.44e-06	3.29e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—EGFR—brain cancer	3.44e-06	3.29e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MYC—brain cancer	3.43e-06	3.28e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VEGFA—brain cancer	3.42e-06	3.28e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TP53—brain cancer	3.41e-06	3.26e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MYC—brain cancer	3.4e-06	3.25e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MYC—brain cancer	3.39e-06	3.24e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—STAT3—brain cancer	3.39e-06	3.24e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—EGFR—brain cancer	3.39e-06	3.24e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—EGFR—brain cancer	3.38e-06	3.23e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—EGFR—brain cancer	3.37e-06	3.22e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—EGFR—brain cancer	3.36e-06	3.21e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—EGFR—brain cancer	3.32e-06	3.18e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—EGFR—brain cancer	3.32e-06	3.17e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TP53—brain cancer	3.29e-06	3.15e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TP53—brain cancer	3.27e-06	3.13e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TP53—brain cancer	3.18e-06	3.05e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MYC—brain cancer	3.15e-06	3.01e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TP53—brain cancer	3.13e-06	3e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—EGFR—brain cancer	3.08e-06	2.95e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PIK3CG—brain cancer	2.92e-06	2.79e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TP53—brain cancer	2.89e-06	2.76e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TP53—brain cancer	2.84e-06	2.72e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TP53—brain cancer	2.84e-06	2.71e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TP53—brain cancer	2.83e-06	2.71e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TP53—brain cancer	2.82e-06	2.7e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TP53—brain cancer	2.79e-06	2.67e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TP53—brain cancer	2.78e-06	2.66e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TP53—brain cancer	2.59e-06	2.48e-05	CbGpPWpGaD
